Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3422]
News [7828]
Articles [63]
Editorials [9]
Conferences [210]
elearning [49]
The potential of epigenetics in cancer treatment
Dr Peter Jones - University of Southern California, USA
The potential of epigenetics in cancer treatment ( Dr Peter Jones - University of Southern California, USA )
17 Aug 2010
Patient uptake in clinical trials
Prof Stephen O'Brien, Newcastle University UK
Patient uptake in clinical trials ( Prof Stephen O'Brien, Newcastle University UK )
26 Jul 2010
Communication skills in clinical practice
Dr Steve Johnson - Yeovil District Hospital, UK
Communication skills in clinical practice ( Dr Steve Johnson - Yeovil District Hospital, UK )
26 Jul 2010
Factors influencing the choice of bone metastases treatment
Professor Robert Coleman, Weston Park Hospital, Sheffield, UK
Factors influencing the choice of bone metastases treatment ( Professor Robert Coleman, Weston Park Hospital, Sheffield, UK )
23 Jul 2010
Costs and benefits of bone metastases therapies
Professor Robert Coleman, Weston Park Hospital, Sheffield, UK
Costs and benefits of bone metastases therapies ( Professor Robert Coleman, Weston Park Hospital, Sheffield, UK )
23 Jul 2010
The launch of Sarah Cannon Research UK and research developments at ASCO 2010
Dr Jeffrey Infante - Sarah Cannon Research Institute, USA
The launch of Sarah Cannon Research UK and research developments at ASCO 2010 ( Dr Jeffrey Infante - Sarah Cannon Research Institute, USA )
22 Jul 2010
Systemic therapy - what lies ahead?
Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France
Systemic therapy - what lies ahead? ( Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France )
20 Jul 2010
Ovarian cancer research
Professor Stan Kaye - Institute of Cancer Research, London, UK
Ovarian cancer research ( Professor Stan Kaye - Institute of Cancer Research, London, UK )
20 Jul 2010
ALK mutation related non-small cell lung cancer
Prof George Demetri - Harvard Medical School, USA
ALK mutation related non-small cell lung cancer ( Prof George Demetri - Harvard Medical School, USA )
20 Jul 2010
The PRIMA study
Prof Gilles Salles - Universite Claude Bernard Lyon, France
The PRIMA study ( Prof Gilles Salles - Universite Claude Bernard Lyon, France )
20 Jul 2010
Biotherapy Development Association
Prof Heinz Zwierzina - Innsbruck Medical University, Austria
Biotherapy Development Association ( Prof Heinz Zwierzina - Innsbruck Medical University, Austria )
20 Jul 2010
PARP inhibitors
Professor Hilary Calvert - University College London, UK
PARP inhibitors ( Professor Hilary Calvert - University College London, UK )
20 Jul 2010

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation